Wellgistics Health appoints UHY LLP as new auditor, dismisses Suri & Co.

Published 08/07/2025, 22:18
Wellgistics Health appoints UHY LLP as new auditor, dismisses Suri & Co.

Wellgistics Health , Inc. (NASDAQ:WGRX) announced Monday that its board of directors approved the dismissal of Suri & Co., Chartered Accountants as the company’s independent registered public accounting firm, and appointed UHY LLP as its new auditor effective the same day.

According to the company’s statement in a Securities and Exchange Commission filing, Suri & Co.’s audit reports on Wellgistics Health’s consolidated financial statements for the years ended December 31, 2024 and 2023 included a note regarding the company’s ability to continue as a going concern. Other than this note, Suri & Co.’s reports did not contain any adverse opinions, disclaimers of opinion, or qualifications as to uncertainty, audit scope, or accounting principles.

The filing further stated that during the fiscal years ended December 31, 2024 and 2023, as well as the interim period through July 7, 2025, there were no disagreements between Wellgistics Health and Suri & Co. on any matters of accounting principles, practices, financial statement disclosure, or auditing scope or procedures that would have required disclosure. The company also reported that there were no reportable events as defined by SEC regulations during this period.

Wellgistics Health has provided Suri & Co. with a copy of the disclosures in the current report and requested that Suri & Co. furnish a letter addressed to the SEC stating whether it agrees with the statements made. A copy of this letter, dated Tuesday, was filed as an exhibit to the report.

The company also confirmed that, prior to the appointment, neither Wellgistics Health nor anyone acting on its behalf consulted with UHY LLP regarding the application of accounting principles to a specific transaction or the type of audit opinion that might be rendered on the company’s financial statements, nor were there any matters that were the subject of a disagreement or reportable event.

This information is based on a statement made in a press release filed with the Securities and Exchange Commission.

In other recent news, Wellgistics Health, Inc. has announced several strategic initiatives and developments. The company has adopted XRP, a blockchain-based digital asset, for its treasury reserves and real-time payments, supported by a $50 million Equity Line of Credit. This adoption aims to enhance transaction speed, reduce costs, and increase transparency within its healthcare network. In another significant move, Wellgistics Health has converted $1.5 million of debt into 333,333 shares of common stock, with CEO Brian Norton committing to hold these shares under a 12-month lock-up agreement. Additionally, Wellgistics Health has acquired Peek Healthcare Technologies, Inc., which operates the Peek Meds Marketplace, to enhance its digital healthcare ecosystem and offer real-time prescription pricing transparency. This acquisition is expected to reduce prescription costs and expand commercialization services for pharmaceutical manufacturers. The company also highlights its focus on creating a micro health ecosystem through integrated solutions for pharmacies and healthcare providers. These recent developments underscore Wellgistics Health’s commitment to innovation and efficiency in the healthcare sector.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.